Psychedelic biopharmaceutical company GH Research saw its shares pop over 15% in trading after the company was named in a hedge fund purchase.
Category Investment
Published in Green Market Report
Psychedelic biopharmaceutical company GH Research saw its shares pop over 15% in trading after the company was named in a hedge fund purchase.